Predictive Genetic Testing And Consumer/Wellness Genomics Market By Application And Trend Analysis From 2013 To 2025

  • ID: 4076541
  • Report
  • 220 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • 123andMe, Inc.
  • Applied Biosystems
  • Color Genomics, Inc.
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • QIAGEN
  • MORE
The global predictive genetic testing & consumer/wellness genomics market is anticipated to reach USD 4.6 billion by 2025. Key drivers attributing to the market expansion include rising awareness pertaining to the use of genomic tests for the prediction of gene susceptibility for probability of disease development. Genetic data in the ecosystem increases when consumers buy direct-to-consumer genomics products or participate in clinical research trials.

Rising encouragement for the use of these products is anticipated to propel industrial growth. Expansion in the range of consumer genetic tests by market entities is anticipated to fuel progress in the market in the coming years. Introduction of novel platforms anticipates the DNA-powered applications thus rising market penetration.

Moreover, the pharmaceutical companies are also engaged in partnerships with genomics companies in order to develop novel therapeutics on the basis of genotypic and phenotypic correlations. For instance, in April 2016 a ten-year deal was signed between Human Longevity Inc. (HLI) and AstraZeneca, in which HLI is supposed to sequence 500,000 genomes of the clinical trial population of AstraZeneca. This data is to be used for the identification of novel drug targets. The deal also provides AstraZeneca with access to the proprietary knowledgebase in order augment biomarker discovery, and facilitate drug development.

Further Key Findings from the Study Suggest:

Application of genetic susceptibility tests in gynecology and endocrinology, is of great interest thereby resulting to higher adoption.

These tests enable the identification of the susceptibility of genes towards postmenopausal osteoporosis, adenomyosis, and endometriosis.

Breast & ovarian cancer based predictive testing accounted for the largest share owing to the rising use of susceptibility testing for BRCA mutations cancer prediction.

Government and pertinent organizations are engaged in endeavors aimed at curbing cancer-related healthcare expenditure by encouraging patients to undergo regular diagnostic examinations.

CRC screening initiatives undertaken by the governments and implementation of mass CRC screening programs is expected to increase the demand for CRC screening tests.

Asia Pacific is anticipated to witness substantial growth in the coming years owing to accelerated uptake of these predictive tests in the developing economies of this region.

Key players contributing in this market are BGI, Illumina, Inc, Pathway Genomics, Genesis Genetics, 23andMe, Inc, ARUP Laboratories, Color Genomics Inc., and Myriad Genetics, Inc.

These entities are involved in collaborations in order to develop their portfolio with respect to fragmented point-solutions across the genomics value chain.
PLEASE NOTE: This report will be completed after order and will take approximately 1-2 business days after the confirmation of payment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 123andMe, Inc.
  • Applied Biosystems
  • Color Genomics, Inc.
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • QIAGEN
  • MORE
1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis

2 Executive Summary

3 Predictive Genetic Testing & Consumer/Wellness Genomics Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market Driver Analysis
3.1.1.1 Rise in number of novel partnership models
3.1.1.2 Introduction of fragmented point-solutions across the genomics value chain
3.1.1.3 Exponentially decreasing costs for genetic sequencing
3.1.1.4 Introduction of technological advancements in cloud computing and data integration
3.1.2 Market Restraint Analysis
3.1.2.1 Absence of well-defined regulatory framework and low adoption rate
3.1.2.2 Ethical concerns pertaining to implementation
3.2 Penetration & Growth Prospect Mapping for Applications, 2015
3.3 Predictive genetic testing & consumer/wellness genomics-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis - Porter’s

4 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Test Type Estimates & Trend Analysis
4.1 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Test Types Movement Analysis
4.2 Predictive Testing
4.2.1 Global predictive testing market, 2013 - 2025 (USD Million)
4.2.2 Genetic susceptibility test
4.2.2.1 Global genetic susceptibility test market, 2013 - 2025 (USD Million)
4.2.3 Predictive diagnostics
4.2.3.1 Global predictive diagnostics test market, 2013 - 2025 (USD Million)
4.2.4 Population screening programs
4.2.4.1 Global population screening programs market, 2013 - 2025 (USD Million)
4.3 Consumer Genomics
4.3.1 Global consumer genomics market, 2013 - 2025 (USD Million)
4.4 Wellness Genetics
4.4.1 Global wellness genetics market, 2013 - 2025 (USD Million)
4.4.2 Nutria Genetics
4.4.2.1 Global nutria genetics market, 2013 - 2025 (USD Million)
4.4.3 Skin & Metabolism Genetics
4.4.3.1 Global skin & metabolism genetics market, 2013 - 2025 (USD Million)
4.4.4 Others
4.4.4.1 Global others market, 2013 - 2025 (USD Million)

5 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Application Estimates & Trend Analysis
5.1 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Application Movement Analysis
5.2 Breast & Ovarian Cancer Screening
5.2.1 Global breast & ovarian cancer screening market, 2013 - 2025 (USD Million)
5.3 Cardiovascular Screening
5.3.1 Global cardiovascular screening market, 2013 - 2025 (USD Million)
5.4 Diabetic Screening & Monitoring
5.4.1 Global diabetic screening & monitoring market, 2013 - 2025 (USD Million)
5.5 Colon Cancer Screening
5.5.1 Global colon cancer screening market, 2013 - 2025 (USD Million)
5.6 Parkinsonism / Alzheimer’s disease
5.6.1 Global Parkinsonism / Alzheimer’s disease market, 2013 - 2025 (USD Million)
5.7 Urologic Screening/ Prostate Cancer Screening
5.7.1 Global urologic screening/ prostate cancer screening market, 2013 - 2025 (USD Million)
5.8 Orthopedic & Musculoskeletal Screening
5.8.1 Global orthopedic & musculoskeletal screening market, 2013 - 2025 (USD Million)
5.9 Other Cancer Screening
5.9.1 Global other cancer screening market, 2013 - 2025 (USD Million)
5.10 Other Diseases Screening
5.10.2 Global other diseases screening market, 2013 - 2025 (USD Million)

6 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Regional Estimates & Trend Analysis, by Test Type & Application
6.1 Predictive Genetic Testing & Consumer/Wellness Genomics Market Share By Region, 2015 & 2025
6.2 North America
6.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
6.2.2 U.S.
6.2.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
6.2.3 Canada
6.2.3.1 Predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
6.3 Europe
6.3.1 Predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
6.3.2 Germany
6.3.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
6.3.3 UK
6.3.3.1 Predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
6.4.2 Japan
6.4.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
6.4.3 China
6.4.3.1 Predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
6.4.4 Australia
6.4.4.1 Predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
6.4.5 India
6.4.5.1 Predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
6.4.6 Singapore
6.4.6.1 Predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
6.5 Latin America
6.5.1 Predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
6.5.2 Brazil
6.5.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
6.6 MEA
6.6.1 Predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
6.6.2 South Africa
6.6.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)

7 Competitive Landscape
7.1 Strategy framework
7.2 Market participation categorization
7.2.1 Key Initiatives
7.3 Company Profiles
7.3.1 F. Hoffmann-La Roche Ltd
7.3.1.1 Company overview
7.3.1.1.1 454 Life Sciences (Roche Diagnostics Corporation)
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Abbott (Abbott Diagnostics)
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 Thermo Fisher Scientific, Inc.
7.3.3.1 Company overview
7.3.3.1.1 Affymetrix, Inc.
7.3.3.1.2 Applied Biosystems
7.3.3.2 Financial performance
7.3.3.2.1 Financial performance (Affymetrix)
7.3.3.3 Product benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Agilent Technologies
7.3.4.1 Company overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.5 BGI
7.3.5.1 Company overview
7.3.5.1.1 Complete Genomics Incorporated
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Bio-Rad Laboratories, Inc.
7.3.6.1 Company overview
7.3.6.1.1 GnuBIO, Inc.
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 Illumina, Inc.
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.7.4 Strategic initiatives
7.3.8 QIAGEN
7.3.8.1 Company overview
7.3.8.2 Financial performance
7.3.8.3 Product benchmarking
7.3.8.4 Strategic initiatives
7.3.9 Alere
7.3.9.1 Company overview
7.3.9.2 Financial performance
7.3.9.3 Product benchmarking
7.3.9.4 Strategic initiatives
7.3.10 Myriad Genetics, Inc.
7.3.10.1 Company overview
7.3.10.2 Financial performance
7.3.10.3 Product benchmarking
7.3.10.4 Strategic initiatives
7.3.11 Siemens Healthineers
7.3.11.1 Company overview
7.3.11.2 Financial performance
7.3.11.3 Product benchmarking
7.3.11.4 Strategic initiatives
7.3.12 Pathway Genomics
7.3.12.1 Company overview
7.3.12.2 Financial performance
7.3.12.3 Product benchmarking
7.3.12.4 Strategic initiatives
7.3.13 Cooper Surgical, Inc.
7.3.13.1 Company overview
7.3.13.1.1 Genesis Genetics
7.3.13.1.2 Reprogenetics
7.3.13.1.3 Financial performance
7.3.13.1.4 Financial performance
7.3.13.2 Product benchmarking
7.3.13.3 Strategic initiatives
7.3.14 Ambry Genetics Corporation
7.3.14.1 Company overview
7.3.14.2 Financial performance
7.3.14.3 Product benchmarking
7.3.14.4 Strategic initiatives
7.3.15 23andMe, Inc.
7.3.15.1 Company overview
7.3.15.2 Financial performance
7.3.15.3 Product benchmarking
7.3.15.4 Strategic initiatives
7.3.16 Danaher
7.3.16.1 Company overview
7.3.16.1.1 Beckman Coulter, Inc.
7.3.16.2 Financial performance
7.3.16.3 Product benchmarking
7.3.16.4 Strategic initiatives
7.3.17 Cepheid
7.3.17.1 Company overview
7.3.17.2 Financial performance
7.3.17.3 Product benchmarking
7.3.17.4 Strategic initiatives
7.3.18 Hologic, Inc. (Gen-Probe Incorporated)
7.3.18.1 Company overview
7.3.18.2 Financial performance
7.3.18.3 Product benchmarking
7.3.18.4 Strategic initiatives
7.3.19 ARUP Laboratories
7.3.19.1 Company overview
7.3.19.2 Financial performance
7.3.19.3 Product benchmarking
7.3.19.4 Strategic initiatives
7.3.20 GUARDANT HEALTH, INC
7.3.20.1 Company overview
7.3.20.2 Financial performance
7.3.20.3 Product benchmarking
7.3.20.4 Strategic initiatives
7.3.21 Advanced Genomic Solutions (AGS) Ltd
7.3.21.1 Company overview
7.3.21.2 Financial performance
7.3.21.3 Product benchmarking
7.3.21.4 Strategic initiatives
7.3.22 EasyDNA
7.3.22.1 Company overview
7.3.22.2 Financial performance
7.3.22.3 Product benchmarking
7.3.22.4 Strategic initiatives
7.3.23 Color Genomics, Inc.
7.3.23.1 Company overview
7.3.23.2 Financial performance
7.3.23.3 Product benchmarking
7.3.23.4 Strategic initiatives
7.3.24 Counsyl, Inc.
7.3.24.1 Company overview
7.3.24.2 Financial performance
7.3.24.3 Product benchmarking
7.3.24.4 Strategic initiatives
7.3.25 Gene by Gene
7.3.25.1 Company overview
7.3.25.2 Financial performance
7.3.25.3 Product benchmarking
7.3.26 Mapmygenome
7.3.26.1 Company overview
7.3.26.2 Financial performance
7.3.26.3 Product benchmarking
7.3.26.4 Strategic initiatives
7.3.27 Interleukin Genetics Inc.
7.3.27.1 Company overview
7.3.27.2 Financial performance
7.3.27.3 Product benchmarking
7.3.27.4 Strategic initiatives
7.3.28 Laboratory Corporation of America Holdings (LabCorp)
7.3.28.1 Company overview
7.3.28.2 Financial performance
7.3.28.3 Product benchmarking
7.3.28.4 Strategic initiatives
7.3.29 Quest Diagnostics Incorporated
7.3.29.1 Company overview
7.3.29.1.1 Sonora Quest Laboratories
7.3.29.2 Financial performance
7.3.29.2.1 Financial performance
7.3.29.3 Product benchmarking
7.3.29.4 Strategic initiatives
7.3.30 Xcode
7.3.30.1 Company overview
7.3.30.2 Financial performance
7.3.30.3 Product benchmarking
7.3.30.4 Strategic initiatives
7.3.31 Amgen, Inc.
7.3.31.1 Company overview
7.3.31.1.1 deCODE genetics
7.3.31.2 Financial performance (Amgen, Inc.)
7.3.31.3 Product benchmarking

List of Tables

Table 1 Funding raised through U.S. government for precision medicine (USD Million)
Table 2 Healthcare expenditure levels, 2012
Table 3 North America predictive genetic testing & consumer/wellness genomics market, by test type, 2013 - 2025 (USD Million)
Table 4 North America predictive testing market, by test, 2013 - 2025 (USD Million)
Table 5 North America wellness genetics market, by application, 2013 - 2025 (USD Million)
Table 6 North America predictive genetic testing & consumer genomics market, by application, 2013 - 2025 (USD Million)
Table 7 U.S. predictive genetic testing & consumer/wellness genomics market, by test type, 2013 - 2025 (USD Million)
Table 8 U.S. predictive testing market, by test, 2013 - 2025 (USD Million)
Table 9 U.S. wellness genetics market, by application, 2013 - 2025 (USD Million)
Table 10 U.S. predictive genetic testing & consumer genomics market, by application, 2013 - 2025 (USD Million)
Table 11 Canada predictive genetic testing & consumer/wellness genomics market, by test type, 2013 - 2025 (USD Million)
Table 12 Canada predictive testing market, by test, 2013 - 2025 (USD Million)
Table 13 Canada wellness genetics market, by application, 2013 - 2025 (USD Million)
Table 14 Canada predictive genetic testing & consumer genomics market, by application, 2013 - 2025 (USD Million)
Table 15 Europe predictive genetic testing & consumer/wellness genomics market, by test type, 2013 - 2025 (USD Million)
Table 16 Europe predictive testing market, by test, 2013 - 2025 (USD Million)
Table 17 Europe wellness genetics market, by application, 2013 - 2025 (USD Million)
Table 18 Europe predictive genetic testing & consumer genomics market, by application, 2013 - 2025 (USD Million)
Table 19 Germany predictive genetic testing & consumer/wellness genomics market, by test type, 2013 - 2025 (USD Million)
Table 20 Germany predictive testing market, by test, 2013 - 2025 (USD Million)
Table 21 Germany wellness genetics market, by application, 2013 - 2025 (USD Million)
Table 22 Germany predictive genetic testing & consumer genomics market, by application, 2013 - 2025 (USD Million)
Table 23 UK predictive genetic testing & consumer/wellness genomics market, by test type, 2013 - 2025 (USD Million)
Table 24 UK predictive testing market, by test, 2013 - 2025 (USD Million)
Table 25 UK wellness genetics market, by application, 2013 - 2025 (USD Million)
Table 26 UK predictive genetic testing & consumer genomics market, by application, 2013 - 2025 (USD Million)
Table 27 Asia Pacific predictive genetic testing & consumer/wellness genomics market, by test type, 2013 - 2025 (USD Million)
Table 28 Asia Pacific predictive testing market, by test, 2013 - 2025 (USD Million)
Table 29 Asia Pacific wellness genetics market, by application, 2013 - 2025 (USD Million)
Table 30 Asia Pacific predictive genetic testing & consumer genomics market, by application, 2013 - 2025 (USD Million)
Table 31 Japan predictive genetic testing & consumer/wellness genomics market, by test type, 2013 - 2025 (USD Million)
Table 32 Japan predictive testing market, by test, 2013 - 2025 (USD Million)
Table 33 Japan wellness genetics market, by application, 2013 - 2025 (USD Million)
Table 34 Japan predictive genetic testing & consumer genomics market, by application, 2013 - 2025 (USD Million)
Table 35 Availability of specific services in China market of predictive genetic testing & consumer/wellness genomics
Table 36 China predictive genetic testing & consumer/wellness genomics market, by test type, 2013 - 2025 (USD Million)
Table 37 China predictive testing market, by test, 2013 - 2025 (USD Million)
Table 38 China wellness genetics market, by application, 2013 - 2025 (USD Million)
Table 39 China predictive genetic testing & consumer genomics market, by application, 2013 - 2025 (USD Million)
Table 40 Australia predictive genetic testing & consumer/wellness genomics market, by test type, 2013 - 2025 (USD Million)
Table 41 Australia predictive testing market, by test, 2013 - 2025 (USD Million)
Table 42 Australia wellness genetics market, by application, 2013 - 2025 (USD Million)
Table 43 Australia predictive genetic testing & consumer genomics market, by application, 2013 - 2025 (USD Million)
Table 44 India predictive genetic testing & consumer/wellness genomics market, by test type, 2013 - 2025 (USD Million)
Table 45 India predictive testing market, by test, 2013 - 2025 (USD Million)
Table 46 India wellness genetics market, by application, 2013 - 2025 (USD Million)
Table 47 India predictive genetic testing & consumer genomics market, by application, 2013 - 2025 (USD Million)
Table 48 Singapore predictive genetic testing & consumer/wellness genomics market, by test type, 2013 - 2025 (USD Million)
Table 49 Singapore predictive testing market, by test, 2013 - 2025 (USD Million)
Table 50 Singapore wellness genetics market, by application, 2013 - 2025 (USD Million)
Table 51 Singapore predictive genetic testing & consumer genomics market, by application, 2013 - 2025 (USD Million)
Table 52 Latin America predictive genetic testing & consumer/wellness genomics market, by test type, 2013 - 2025 (USD Million)
Table 53 Latin America predictive testing market, by test, 2013 - 2025 (USD Million)
Table 54 Latin America wellness genetics market, by application, 2013 - 2025 (USD Million)
Table 55 Latin America predictive genetic testing & consumer genomics market, by application, 2013 - 2025 (USD Million)
Table 56 Brazil predictive genetic testing & consumer/wellness genomics market, by test type, 2013 - 2025 (USD Million)
Table 57 Brazil predictive testing market, by test, 2013 - 2025 (USD Million)
Table 58 Brazil wellness genetics market, by application, 2013 - 2025 (USD Million)
Table 59 Brazil predictive genetic testing & consumer genomics market, by application, 2013 - 2025 (USD Million)
Table 60 MEA predictive genetic testing & consumer/wellness genomics market, by test type, 2013 - 2025 (USD Million)
Table 61 MEA predictive testing market, by test, 2013 - 2025 (USD Million)
Table 62 MEA wellness genetics market, by application, 2013 - 2025 (USD Million)
Table 63 MEA predictive genetic testing & consumer genomics market, by application, 2013 - 2025 (USD Million)
Table 64 South Africa predictive genetic testing & consumer/wellness genomics market, by test type, 2013 - 2025 (USD Million)
Table 65 South Africa predictive testing market, by test, 2013 - 2025 (USD Million)
Table 66 South Africa wellness genetics market, by application, 2013 - 2025 (USD Million)
Table 67 South Africa predictive genetic testing & consumer genomics market, by application, 2013 - 2025 (USD Million)

List of Figures

Figure 1 Market research process
Figure 2 Information Procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain based sizing & forecasting
Figure 6 QFD modelling for market share assessment
Figure 7 Market Summary
Figure 8 Market trends & outlook
Figure 9 Market segmentation & scope
Figure 10 Market driver relevance analysis (current & future impact)
Figure 11 Consumer genomics: Partnership trends
Figure 12 Expected rise in expenditure for cancer treatment (USD Billion)
Figure 13 Consumer genomics: Value chain analysis
Figure 14 Cost per raw megabase (Mb) of DNA sequence (USD)
Figure 15 Cost per genome
Figure 16 Market restraint relevance analysis (current & future impact)
Figure 17 Genomics percentage adoption by category
Figure 18 Penetration & growth prospect mapping for Applications, 2015
Figure 19 SWOT Analysis, By Factor (political & legal, economic and technological)
Figure 20 Porter’s Five Forces Analysis
Figure 21 Predictive genetic testing & consumer/wellness genomics market: Test types outlook key takeaways
Figure 22 Predictive genetic testing & consumer/wellness genomics market: Test types movement analysis
Figure 23 Global predictive testing market, 2013 - 2025 (USD Million)
Figure 24 Global genetic susceptibility test market, 2013 - 2025 (USD Million)
Figure 25 Global predictive diagnostics market, 2013 - 2025 (USD Million)
Figure 26 Global population screening programs market, 2013 - 2025 (USD Million)
Figure 27 Categories of tests offered by Direct-To-Consumer (DTC) companies
Figure 28 Global consumer genomics market, 2013 - 2025 (USD Million)
Figure 29 Global wellness genetics market, 2013 - 2025 (USD Million)
Figure 30 Country-wise contribution to nutrigenomics research
Figure 31 Global nutria genetics market, 2013 - 2025 (USD Million)
Figure 32 Global skin & metabolism genetics market, 2013 - 2025 (USD Million)
Figure 33 Global others market, 2013 - 2025 (USD Million)
Figure 34 Predictive genetic testing & consumer/wellness genomics market: Application outlook key takeaways
Figure 35 Global predictive genetic testing & consumer/wellness genomics market: Application movement analysis
Figure 36 Global breast & ovarian cancer market, 2013 - 2025 (USD Million)
Figure 37 Global cardiovascular screening market, 2013 - 2025 (USD Million)
Figure 38 Global diabetic screening & monitoring market, 2013 - 2025 (USD Million)
Figure 39 Global colon cancer market, 2013 - 2025 (USD Million)
Figure 40 Global Parkinsonism / Alzheimer’s disease market, 2013 - 2025 (USD Million)
Figure 41 Global urologic screening/ prostate cancer screening market, 2013 - 2025 (USD Million)
Figure 42 Global orthopedic & musculoskeletal market, 2013 - 2025 (USD Million)
Figure 43 Global other cancer screening market, 2013 - 2025 (USD Million)
Figure 44 Global other diseases market, 2013 - 2025 (USD Million)
Figure 45 Regional market place: Key takeaway
Figure 46 Predictive genetic testing & consumer/wellness genomics regional outlook, 2015 & 2025
Figure 47 North America predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
Figure 48 U.S predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
Figure 49 Canada predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
Figure 50 Europe predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
Figure 51 Germany predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
Figure 52 UK predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
Figure 53 Asia Pacific predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
Figure 54 Japan predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
Figure 55 China predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
Figure 56 Australia predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
Figure 57 India predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
Figure 58 Singapore predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
Figure 59 Latin America predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
Figure 60 Brazil predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
Figure 61 MEA predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
Figure 62 South Africa predictive genetic testing & consumer/wellness genomics market, 2013 - 2025 (USD Million)
Figure 63 Strategy framework
Figure 64 Participant categorization
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • F. Hoffmann-La Roche Ltd
  • 45 Life Sciences (Roche Diagnostics Corporation)
  • Abbott (Abbott Diagnostics)
  • Thermo Fisher Scientific, Inc.
  • Affymetrix, Inc.
  • Applied Biosystems
  • Agilent Technologies
  • BGI
  • Complete Genomics Incorporated
  • Bio-Rad Laboratories, Inc.
  • GnuBIO, Inc.
  • Illumina, Inc.
  • QIAGEN
  • Alere
  • Myriad Genetics, Inc.
  • Siemens Healthineers
  • Pathway Genomics
  • Cooper Surgical, Inc.
  • Genesis Genetics
  • Reprogenetics
  • Ambry Genetics Corporation
  • 123andMe, Inc.
  • Danaher
  • Beckman Coulter, Inc.
  • Cepheid
  • Hologic, Inc. (Gen-Probe Incorporated)
  • ARUP Laboratories
  • GUARDANT HEALTH, INC
  • Advanced Genomic Solutions (AGS) Ltd
  • EasyDNA
  • Color Genomics, Inc.
  • Counsyl, Inc.
  • Gene by Gene
  • Mapmygenome
  • Interleukin Genetics Inc.
  • Laboratory Corporation of America Holdings (LabCorp)
  • Quest Diagnostics Incorporated
  • Sonora Quest Laboratories
  • Xcode
  • Amgen, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll